CSPC Pharmaceutical Group is a pharmaceutical company based in Shijiazhuang, China. It develops, makes and markets finished medicines and bulk pharmaceutical ingredients, with products spanning antibiotics, medicines for heart and blood-vessel conditions, and treatments for cancer. The company supplies hospitals, clinics and distributors, chiefly in its home market, and also exports active ingredients and finished products to customers abroad. Its operations combine research and development with large-scale manufacturing of both generic medicines and pharmaceutical raw materials.
The shares are listed on the Hong Kong Stock Exchange in Hong Kong under the code 1093, and the price on this page is in Hong Kong dollars (HKD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Strong price profile
Ranks #280 of 2611 on the Hong Kong Stock Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Hong Kong yet.
TrendStrong
80/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average2.9%
From 52-week high-14.7%
MomentumStrong
70/100
Rising faster than most stocks on this exchange.
See the numbers →
3-month return6.1%
6-month return1.8%
12-month, skipping last month-2.3%
Stability (higher is calmer)Fair
67/100
Typical risk for this exchange.
See the numbers →
Volatility, 1 year (lower is calmer)47.0%
Worst drawdown, 1 year (smaller is calmer)-36.4%
LiquidityStrong
98/100
Trades actively.
See the numbers →
Avg daily value traded795.30M HKD
Zero-volume days0.0%
IncomeWeak
37/100
Dividend is small or irregular.
See the numbers →
Dividend yield1.7%
Years with dividends5
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Hong Kong when fundamentals data for this market is added. All Hong Kong stocks.
52-wk range 6.387 – 10.720Daily closes, split-adjusted
Signals
50-day average9.218
200-day average8.668
Golden/death cross (60d)Golden, 33 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.383
Technical summary
Daily
Neutral
7 bullish · 1 neutral · 8 bearish
Weekly
Strongly bullish
9 bullish · 1 neutral · 2 bearish
Monthly
Strongly bullish
7 bullish · 1 neutral · 0 bearish
Moving averages (daily)
SMA 10
9.17
Bearish
EMA 10
9.10
Bearish
SMA 20
9.41
Bearish
EMA 20
9.21
Bearish
SMA 50
9.22
Bearish
EMA 50
9.09
Bearish
SMA 100
8.46
Bullish
EMA 100
8.82
Bullish
SMA 200
8.67
Bullish
EMA 200
8.55
Bullish
Oscillators (daily)
RSI (14)
42.69
Neutral
MACD (12, 26)
-0.08
Bearish
Momentum (12)
-11.42
Bearish
Stochastic %K (14)
18.95
Bullish
Williams %R (14)
-81.05
Bullish
CCI (20)
-115.9
Bullish
Pivot points (classic, last session)
S3
8.33
S2
8.48
S1
8.70
Pivot
8.85
R1
9.07
R2
9.22
R3
9.44
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
0.15 HKD
Yield on today's price
1.68%
Frequency
Annual
Next ex-dividend date
Not announced
Ex-dividend date
Amount per share
24 Jun 2026
0.1500
17 Oct 2025
0.1400
4 Jun 2025
0.1000
31 Oct 2024
0.1600
31 May 2024
0.1400
7 Sep 2023
0.1400
5 Jun 2023
0.1100
8 Sep 2022
0.1000
31 May 2022
0.1000
10 Sep 2021
0.0800
24 May 2021
0.0900
10 Sep 2020
0.0600
Ex-dividend dates and amounts from EODHD. Shown as declared, before tax.
Prices are end-of-day closes in HKD. Educational only, not financial advice.